Chinese scientists use AI to rapidly develop promising new weight-loss drug

Chinese scientists use AI to develop new weight-loss drug that also treats type 2 diabetes. It entered phase 2 trials after successful phase 1.
The drug was developed quickly (19 months) thanks to AI computing platform Molecule Pro. It identifies targets, predicts protein structures, and designs tailored drugs.
In tests, the drug helped obese monkeys lose weight without rebound effects. It can be taken orally unlike similar drugs.
AI drug development cuts costs and time while ensuring effectiveness and safety, increasing competitiveness.
AI can enable Chinese pharma to catch up and develop drugs with more international influence. It can solve problems traditional methods cannot.

scmp.com

Relevant topic timeline:

8/21/2023

Beijing to restrict use of generative AI in online healthcare activities

Beijing is taking steps to limit the use of artificial intelligence in online healthcare services, including medical diagnosis, as the technology continues to disrupt traditional occupations and industries in China.

8/31/2023

India's AI biotech takes on diabetes epidemic

India has the highest number of people with diabetes, with an estimated 101 million individuals living with the condition, and artificial intelligence technology offers potential solutions for early detection and personalized treatment.

9/2/2023

How the Medical Industry Could Produce the Biggest AI Stock Winners

Artificial intelligence has the potential to revolutionize the medical industry by quickly discovering new drug candidates and extending human lifespans through therapies that repair damage to cells and tissues, leading to a projected $50 billion AI drug discovery revolution and the possibility of living to 150 years old.

9/22/2023

AI Speeds Up Patient Recruitment and Reduces Costs of Clinical Drug Trials

Major drugmakers are using artificial intelligence (AI) to accelerate drug development by quickly finding patients for clinical trials and reducing the number of participants needed, potentially saving millions of dollars. AI is increasingly playing a substantial role in human drug trials, with companies such as Amgen, Bayer, and Novartis using AI tools to scan vast amounts of medical data and identify suitable trial patients, significantly reducing the time and cost of recruitment. The use of AI in drug development is on the rise, with the US FDA receiving over 300 applications that incorporate AI or machine learning in drug development from 2016 through 2022.

10/4/2023

Fitbit Takes on Apple with New AI Health Coach

Fitbit Labs is introducing a new program that uses AI to analyze health and fitness data, providing personalized insights and trends to help users understand their health better.

10/10/2023

AI Holds Promise to Speed Drug Discovery But Verification, Collaboration Needed

Generative artificial intelligence (AI) is potentially shortening the drug discovery process before clinical trials, according to claims made by companies, but independent verification and clinical trials are needed to determine its efficacy.

10/13/2023

Moderna and Recursion Use AI to Accelerate Drug Development, But Recursion's Widening Losses Raise Concerns

Artificial intelligence (AI) has the potential to revolutionize healthcare, making it a lucrative market for investors, with Moderna being a top AI stock to buy due to its use of AI in drug development and potential for significant earnings growth, while Recursion Pharmaceuticals should be avoided due to the uncertainty surrounding its ability to speed up the drug development process.

10/19/2023

AI Can Diagnose Diabetes in Seconds Just by Your Voice

Artificial intelligence can accurately detect type 2 diabetes by analyzing a patient's voice in just a few seconds, potentially transforming how the medical community screens for the disease.

Topics

Posted 9/29/2023, 8:00:09 AM